Tirzepatide's dual-agonist profile is investigated across the standard tiers of preclinical research, from receptor assays to whole-animal models.
In-vitro work
Cell-based assays characterize binding affinity and signaling (such as cAMP response) at both the GIP and GLP-1 receptors, establishing relative potency and selectivity at defined in-vitro concentrations — never human dosing.
Animal-model research
Rodent and other metabolic models study how simultaneous engagement of two incretin pathways behaves in a whole organism, frequently with single agonists and the triple agonist retatrutide as comparators. Background: mechanism of action and semaglutide vs tirzepatide.
Product page: Tirzepatide research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.